In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Corcept Therapeutics Inc (NASDAQ: CORT) closed at $62.24 down -3.65% from its previous closing price of $64.60. In other words, the price has decreased by -$3.65 from its previous closing price. On the day, 1.58 million shares were traded. CORT stock price reached its highest trading level at $65.1 during the session, while it also had its lowest trading level at $61.935.
Ratios:
For a deeper understanding of Corcept Therapeutics Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.13 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 33.52. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 3.35. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 10 ’25 when Swisher Daniel N JR sold 2,200 shares for $70.22 per share. The transaction valued at 154,484 led to the insider holds 0 shares of the business.
Swisher Daniel N JR bought 2,200 shares of CORT for $154,484 on Apr 10 ’25. On Mar 31 ’25, another insider, Maduck Sean, who serves as the insider of the company, sold 100,000 shares for $100.54 each. As a result, the insider received 10,054,010 and left with 85,622 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORT now has a Market Capitalization of 6566507008 and an Enterprise Value of 6190135808. As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 50.47, and their Forward P/E ratio for the next fiscal year is 18.65. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.72. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.73 while its Price-to-Book (P/B) ratio in mrq is 9.63. Its current Enterprise Value per Revenue stands at 9.17 whereas that against EBITDA is 44.939.
Stock Price History:
The Beta on a monthly basis for CORT is 0.41, which has changed by 1.7910314 over the last 52 weeks, in comparison to a change of 0.05430484 over the same period for the S&P500. Over the past 52 weeks, CORT has reached a high of $117.33, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is -4.68%, while the 200-Day Moving Average is calculated to be 22.10%.
Shares Statistics:
For the past three months, CORT has traded an average of 1.53M shares per day and 1740820 over the past ten days. A total of 105.11M shares are outstanding, with a floating share count of 93.22M. Insiders hold about 11.64% of the company’s shares, while institutions hold 80.35% stake in the company. Shares short for CORT as of 1743379200 were 16526709 with a Short Ratio of 10.83, compared to 1740700800 on 16042575. Therefore, it implies a Short% of Shares Outstanding of 16526709 and a Short% of Float of 21.93.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
